Preferred Label : leukemia, t-cell;
MeSH definition : A malignant disease of the T-LYMPHOCYTES in the bone marrow, thymus, and/or blood.;
MeSH synonym : lymphocytic leukemias, t; leukemias, t-cell; t lymphocytic leukemias; t-lymphocytic leukemia; leukemias, t-lymphocytic; t-cell leukemias; leukemia, lymphocytic, t cell; leukemia, t lymphocytic; t-cell leukemia; lymphocytic leukemias, t-cell; t-cell lymphocytic leukemia; t-cell lymphocytic leukemias; t cell leukemia; leukemia, t-lymphocytic; t-lymphocytic leukemias; t lymphocytic leukemia; leukemias, t lymphocytic; leukemia, lymphocytic, t-cell; lymphocytic leukemia, t-cell; leukemia, t-cell lymphocytic; leukemias, t-cell lymphocytic; lymphocytic leukemia, t cell; lymphocytic leukemia, t; leukemia, T cell;
MeSH annotation : general or unspecified: prefer specifics;
Wikipedia link : https://en.wikipedia.org/wiki/Leukemia, t-cell;
Origin ID : D015458;
UMLS CUI : C0023492;
Allowable qualifiers
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Record concept(s)
Related MeSH Supplementary Concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
A malignant disease of the T-LYMPHOCYTES in the bone marrow, thymus, and/or blood.
https://ansm.sante.fr/informations-de-securite/abecma-breyanzi-carvykti-kymriah-tecartus-et-yescarta-therapies-cellulaires-car-t-dirigees-contre-les-antigenes-cd19-ou-bcma-risque-de-tumeur-maligne-secondaire-issue-de-lymphocytes-t
2024
false
false
false
France
French
pharmacovigilance note
Secondary Malignant Neoplasm
Anti-CD19 CAR T Cells Preparation
Anti-BCMA CAR T Cells Preparation
Chimeric Antigen Receptor Therapy
lymphoma, T-Cell
continuity of patient care
hematologic neoplasms
leukemia, t-cell
Antineoplastic cell and gene therapy
---